MDT monthly performance report
View MDT's monthly returns, drawdown, and seasonality trends — updated every month.
MDT monthly report
—
Key takeaways
- Medtronic (MDT) closed September 2026 at $92.13, up 1.63% for the month and −3.62% over the trailing 12 months.
- Year-to-date, MDT is −4.09%, underperforming the S&P 500 which has returned +11.70% YTD.
- The stock is trading +2.78% versus its 200-day moving average ($89.64), a bullish technical signal.
- Over the past three years, MDT has underperformed the S&P 500 by −60.43%, with a relative strength index reading of 64.8.
- Win rate over the trailing 39 months stands at 51.3% — 20 positive months versus 19 negative months.
Medtronic ended September 2026 at $92.13, posting a monthly return of +1.63%. The S&P 500 returned −0.70% over the same window, leaving relative performance at +2.33%.
The current quarter stands at +17.77% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +2.78% versus the 200-day moving average ($89.64).
Year-to-date, MDT is −4.09% against SPY +11.70%, a gap of −15.79%. The stock is currently −13.35% below its 52-week high, with maximum 3-year drawdown at −30.00%.
| Period | MDT | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.69% | −0.12% | −0.57% |
| 1 Week | +1.29% | −0.34% | +1.63% |
| 1 Month | +1.63% | −0.70% | +2.33% |
| 3 Months | +13.29% | +2.80% | +10.50% |
| 6 Months | +5.73% | +13.85% | −8.12% |
| YTD | −4.09% | +11.70% | −15.79% |
| 12 Months | −3.62% | +15.01% | −18.63% |
| 3 Years | +11.27% | +71.69% | −60.43% |
| Rank | Month | Return |
|---|---|---|
| #1 | Nov 2025 | +16.13% |
| #2 | Jan 2025 | +13.70% |
| #3 | Nov 2023 | +12.34% |
| #4 | Aug 2024 | +10.28% |
| #5 | Jul 2026 | +9.15% |
| Rank | Month | Return |
|---|---|---|
| #1 | Mar 2026 | −11.27% |
| #2 | Oct 2023 | −9.95% |
| #3 | May 2026 | −8.84% |
| #4 | Dec 2025 | −8.80% |
| #5 | Apr 2024 | −7.93% |
| Quarter | Return |
|---|---|
| Q2 2025 | −2.99% |
| Q3 2025 | +9.26% |
| Q4 2025 | +0.86% |
| Q1 2026 | −9.80% |
| Q2 2026 | −9.72% |
| Q3 2026 (QTD) | +17.77% |
| Year | Return |
|---|---|
| 2023 | +6.00% |
| 2024 | −3.03% |
| 2025 | +20.26% |
| 2026 | −4.09% |
| Metric | Value |
|---|---|
| 52-Week High | $106.33 (2025-11-26) |
| 52-Week Low | $73.32 (2026-06-02) |
| Current Price | $92.13 |
| 200-Day Moving Average | $89.64 |
| Price vs 200DMA | +2.78% |
| 3-Year Maximum Drawdown | −30.00% (2026-06-02) |
| Current Drawdown from 52W High | −13.35% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 64.8 |
| 3-Year Excess Return vs S&P 500 | −60.43% |
| RS Peak | 100 (Sep 2023) |
| RS Trough | 52 (Jun 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was MDT's return for this report period?
MDT returned +1.63% in the latest monthly window ending 2026-09-18.
Has MDT outperformed SPY year to date?
YTD MDT: −4.09% vs SPY: +11.70%.
What is MDT's 12-month return?
−3.62% over the trailing 12 months.
Is MDT above or below its 200-day moving average?
Price is +2.78% versus 200DMA ($89.64).
What is the maximum drawdown in the 3-year window?
−30.00% on 2026-06-02.